| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2011 | WO2011066735A1 An Amorolfine HCl Crystal and the Preparation thereof |
| 06/09/2011 | WO2011066684A1 Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 06/09/2011 | WO2011066683A1 Pharmaceutical composition for treating hepatitis |
| 06/09/2011 | WO2011066657A1 Method and composition for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker |
| 06/09/2011 | WO2011066656A1 Compositions comprising igf1 agonists and uses thereof |
| 06/09/2011 | WO2011066653A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same |
| 06/09/2011 | WO2011066651A1 Snalp formulations containing antioxidants |
| 06/09/2011 | WO2011066614A1 Liquid compositions comprising vitamin d and uses thereof |
| 06/09/2011 | WO2011066606A1 Pyranoindole compounds and uses thereof |
| 06/09/2011 | WO2011050054A3 Coumarin compounds as receptor modulators with therapeutic utility |
| 06/09/2011 | WO2011046983A3 Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| 06/09/2011 | WO2011045648A3 Process for preparing (s)-(-)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide and its esters thereof |
| 06/09/2011 | WO2011041596A3 19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring |
| 06/09/2011 | WO2011038446A8 Cosmetic foam |
| 06/09/2011 | WO2011037551A3 Carrying of a combination containing tiotropium in a blister strip |
| 06/09/2011 | WO2011037549A3 Dry powder formulation of tiotropium carried in blister strip |
| 06/09/2011 | WO2011019634A3 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 06/09/2011 | WO2011017634A3 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 06/09/2011 | WO2011016863A9 Methods and uses of cytochrome p450 inhibitors |
| 06/09/2011 | WO2011014661A3 Liver x receptor agonists |
| 06/09/2011 | WO2011011721A9 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 06/09/2011 | WO2011009851A3 Walnut extracts for nutraceutical applications |
| 06/09/2011 | WO2011009826A3 Novel chalcone derivatives with cytotoxic activity |
| 06/09/2011 | WO2011009119A9 Compositions and methods for diagnosing and treating fibrotic disorders |
| 06/09/2011 | WO2011006143A3 Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria |
| 06/09/2011 | WO2010149947A3 Antimicrobial agent |
| 06/09/2011 | WO2010147969A3 Gamma secretase modulators |
| 06/09/2011 | WO2010143168A3 Compounds useful for treating cancer |
| 06/09/2011 | WO2010060186A8 Antibodies that specifically block the biological activity of a tumor antigen |
| 06/09/2011 | WO2010057036A3 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
| 06/09/2011 | WO2009150420A3 Inhibitors of tissue transglutaminase ii as tocolytic agents |
| 06/09/2011 | WO2009010791A3 Cyclic ethers |
| 06/09/2011 | US20110137235 Ultrasonic cancer therapy accelerator |
| 06/09/2011 | US20110136918 Methods of Treating Infectious Diseases |
| 06/09/2011 | US20110136917 Tetrahydro-isoalpha acid compositions and methods for weight management |
| 06/09/2011 | US20110136916 6-shogaol for using in a method for the treatment of leukemia |
| 06/09/2011 | US20110136915 Rapid dissolution formulation of a calcium receptor-active compound |
| 06/09/2011 | US20110136914 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 06/09/2011 | US20110136913 Assessing and treating breast cancer patients |
| 06/09/2011 | US20110136912 Ophthalmic emulsion |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136910 Method for stabilization of s-nitrosoglutathione and composition prepared by the same |
| 06/09/2011 | US20110136909 Method for suppressing excessive appetite |
| 06/09/2011 | US20110136906 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 06/09/2011 | US20110136905 Crystalline teglicar |
| 06/09/2011 | US20110136904 Prostaglandin derivatives |
| 06/09/2011 | US20110136902 12-membered-ring macrolactam derivatives |
| 06/09/2011 | US20110136901 Derivatives of 4-Nerolidylcatechol, Pharmaceutical Compositions Comprising them and Process for Producing The Same |
| 06/09/2011 | US20110136900 Bruise amelioration composition and method of use |
| 06/09/2011 | US20110136899 Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 06/09/2011 | US20110136898 Treatment of retinal degeneration |
| 06/09/2011 | US20110136897 Toll-like receptor 9 agonists for the treatment of anxiety-related disorders and inflammatory disorders |
| 06/09/2011 | US20110136896 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 06/09/2011 | US20110136895 Methods and compositions for modulating PD1 |
| 06/09/2011 | US20110136894 Shortened Alk1 Regulatory Fragment |
| 06/09/2011 | US20110136893 Oligonucleotide-, protein and/or peptide-polymer conjugates |
| 06/09/2011 | US20110136892 Targeting TGF-beta as a Therapy for Alzheimer's Disease |
| 06/09/2011 | US20110136891 Nucleic acid molecules and collections thereof, their application and Identification |
| 06/09/2011 | US20110136890 Treatment of fibrotic conditions |
| 06/09/2011 | US20110136889 Compositions and their uses directed to aceytl-coa carboxylases |
| 06/09/2011 | US20110136888 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 06/09/2011 | US20110136887 Heterocyclic Amide Derivatives as EP4 Receptor Antagonists |
| 06/09/2011 | US20110136886 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them |
| 06/09/2011 | US20110136885 Synergistic Combination of Analgesic Compounds |
| 06/09/2011 | US20110136884 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 06/09/2011 | US20110136883 Granulation of active pharmaceutical ingredients |
| 06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/09/2011 | US20110136880 Latrunculin-Based Macrolides and Their Uses |
| 06/09/2011 | US20110136879 Compound |
| 06/09/2011 | US20110136877 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders |
| 06/09/2011 | US20110136876 Altering Pharmacokinetics of Pirfenidone Therapy |
| 06/09/2011 | US20110136875 Pyrrole Inhibitors of S-Nitrosoglutathione Reductase |
| 06/09/2011 | US20110136873 Inhibitors of Cyclin Dependent Kinases and Their Use |
| 06/09/2011 | US20110136872 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/09/2011 | US20110136871 2-alkoxy-substituted dicyanopyridines and their use |
| 06/09/2011 | US20110136870 Gacyclidine formulations |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136868 Agents for inhibiting osteoclastogenesis and/or osteoclast activation |
| 06/09/2011 | US20110136867 Treatment of Synucleinopathies |
| 06/09/2011 | US20110136865 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| 06/09/2011 | US20110136864 Tetrahydroquinoline indole derivatives and uses thereof |
| 06/09/2011 | US20110136863 N-Heterocyclic M1 Receptor Positive Allosteric Modulators |
| 06/09/2011 | US20110136862 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/09/2011 | US20110136861 Quinolone inhibitors of lipoprotein-associated phospholipase a2 |
| 06/09/2011 | US20110136860 Compounds |
| 06/09/2011 | US20110136859 Compounds |
| 06/09/2011 | US20110136858 Preferred Combination Therapy |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136855 Gemifloxacin process and polymorphs |
| 06/09/2011 | US20110136854 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/09/2011 | US20110136853 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/09/2011 | US20110136852 Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease |
| 06/09/2011 | US20110136851 Sucralose Formulations To Mask Unpleasant Tastes |
| 06/09/2011 | US20110136850 Methods and compositions for topoisomerase i modulated tumor suppression |
| 06/09/2011 | US20110136849 Process for reducing contaminating michael acceptor levels in oxycodone and other compositions |
| 06/09/2011 | US20110136848 Morphinan derivatives for the treatment of drug overdose |
| 06/09/2011 | US20110136847 High Concentration Formulations of Opioids and Opioid Derivatives |
| 06/09/2011 | US20110136846 Buprenorphine Analogs |
| 06/09/2011 | US20110136845 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |